Neurocritical Care
16 cases on osmotic therapy and status epilepticus management, sedation strategy in the acutely injured brain, sympathetic storming and post-arrest sedation, blood-pressure and perfusion-pressure targets, antithrombotic timing after hemorrhage, and thrombectomy anesthesia and shock management — choose a case below to open its full multi-voice debate.
A hardware-store owner arrives with a large basal ganglia hemorrhage and a sluggish, dilating pupil. The osmotic agent chosen in the next ten minutes has to work with his kidneys and his blood pressure, not just his brain.
A 29-year-old teacher's first seizure never stopped, even after benzodiazepines and a second-line load. The next drug has to achieve burst suppression in a patient whose blood pressure is already sliding.
A retired librarian with evolving hemorrhagic contusions keeps thrashing at her endotracheal tube. Enough sedation to keep her safe risks being too much sedation to trust the next neuro check.
A young ironworker's brain injury has stopped bleeding, but his heart rate and temperature keep spiking every time anyone touches him. The question is which drug quiets the storm without also quieting the exam.
A retiree's subdural hematoma has stopped growing on serial scans, but three days of bed rest are stacking his clot risk in the other direction. The team has to decide how soon is actually safe.
A college student's pressures are still climbing after decompressive surgery and every drug tier below this one. Pentobarbital can flatten the pressure, but the evidence behind it has never promised it will save him.
A golfer's heart stopped on the ninth hole and started again twelve minutes later. Now his kidneys are hurting, and the sedative keeping him comfortable through targeted temperature management could quietly outlast the exam meant to tell his family what comes next.
A motorcyclist's brain needs a perfusion pressure the team can actually hold. Her stunned heart, not her vasculature, is what decides which vasopressor gets her there.
A gardener's ruptured aneurysm is secured and she hasn't had a single seizure. The question is whether starting a drug to prevent one she may never have is actually the safer choice.
A retired mail carrier's brain bleed has stopped growing, but the drug-eluting stent in his coronary artery hasn't stopped needing protection. Restarting aspirin and reversing the bleed are two different clocks running at the same time.
A retired choir director's large-vessel stroke is thrombectomy-eligible, but she can't hold still and won't stop trying to sit up. The anesthesia team has to pick an approach the interventionalist can actually work through.
A retired bus driver's pressure is too high to legally give him the clot-busting drug that could reverse his stroke. Getting him under the threshold without overshooting it is its own decision, made against a clock.
A retired kindergarten teacher's lobar hemorrhage touches the cortex, which is exactly the anatomy generations of training taught to fear seizures from. She hasn't had one, and the current guideline doesn't want her treated as if she has.
A football coach's massive stroke didn't fully open with thrombectomy, and his age puts him squarely in the group most likely to swell dangerously over the next two days. Starting osmotic therapy now, before any sign of trouble, sounds protective — the evidence doesn't agree.
A motorcyclist's cervical spinal cord injury calls for a blood pressure target held for days. His bruised lungs are the reason that target might cost him more than it protects.
A high cervical injury has left this patient's heart too slow and his vessels too wide open, a combination the most reflexively reached-for pressor doesn't actually treat.